According to recent reports from Novo Nordisk, insulin should be used by diabetics at an earlier stage as a way to avoid complications and manage the disease more effectively.
A recent study, co-funded by Novo, found that those patients who used injectable insulin rather than oral medication at an early stage were more likely to achieve normal blood glucose levels .
Earlier use will also benefit Novo Nordisk through more widespread sales of the drug. Using insulin more commonly amongst type 2 diabetes sufferers would open a huge market to the insulin manufacturer.
Insulin revenue already accounts for a significant share of the diabetes treatment market, and is climbing faster than oral diabetic medication.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…